Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Neoplasma ; 54(2): 155-61, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17319790

RESUMO

Protein p53 is the tumor suppressor involved in cell cycle control and apoptosis. As a transcription factor p53 controls many cell processes and helps in prevention of cancer development. The p53 gene is polymorphic. Polymorphisms can affect the important regions involved in protein tumor suppressor activity. The well-known polymorphisms are the polymorphisms BstUI in exon 4 and MspI in intron 6. Both are supposed to be associated with cancer development. The purpose of this study was to investigate the genotype frequencies and associations of these polymorphisms with breast cancer in Slovak population. We observed the prevalence of BstUIPro (27.47%) and MspIA1 (17.58%) alleles and BstUIPro/Pro (8.79%) and MspIA1/A1 (5.49%) genotypes in breast cancer patients in comparison with controls 23.40%, 14.10%, 5.77%, 1.92% respectively. However the differences were not significant. After division of the cases and controls according to the age the prevalence of the risk alleles and genotypes in women at the age 50 years or less was higher as compared to women older than 50 years. In the younger women group, the p53 BstUI polymorphism genotype frequencies were 6.2% for BstUIPro/Pro, 31.0% for BstUIArg/Pro and 62.8% for BstUIArg/Arg in controls and 11.11 %, 40.74% and 48.15% in cases respectively. The risk of disease for BstUIPro/Pro genotype was more than two-fold higher in comparison with the BstUIArg/Arg (OR=2.34, 95% CI=0.53-10.24). In p53 MspI the genotype frequencies were 1.77% for MspIA1/A1, 24.78% for MspIA1/A2 and 73.45% for MspIA2/A2 in controls and 11.11%, 18.52% and 70.37% in cases respectively. The risk of disease for MspIA1/A1 genotype was more than six-fold higher in comparison with the MspIA2/A2 (OR=6.55, 95% CI=1.02-41.98). When we evaluated the association of both polymorphisms together with the breast cancer risk we observed that the highest risk was connected with the genotype BstUIPro/Pro / MspIA1/A1 (OR=2.99, 95% CI=0.69-13.06). Our results indicate that both BstUI and MspI p53 polymormphisms might play the role in the breast cancer development especially in women younger than 50 years.


Assuntos
Neoplasias da Mama/genética , Polimorfismo Genético , Proteína Supressora de Tumor p53/genética , Adulto , Idoso , Idoso de 80 Anos ou mais , Alelos , Estudos de Casos e Controles , DNA de Neoplasias/genética , Desoxirribonuclease HpaII/metabolismo , Desoxirribonucleases de Sítio Específico do Tipo II/metabolismo , Feminino , Genótipo , Humanos , Pessoa de Meia-Idade , Mapeamento por Restrição , Fatores de Risco
2.
APMIS ; 114(5): 389-92, 2006 May.
Artigo em Inglês | MEDLINE | ID: mdl-16725017

RESUMO

Pseudoangiomatous stromal hyperplasia (PASH) of the breast is a rare benign proliferation of mesenchymal stromal cells with irregular slit-like formations resembling angiomatous structures. In the majority of cases this lesion is a focal microscopic finding in breast biopsies performed for benign or malignant diseases. It may present in a pure diffuse or nodular form. The exact etiology and pathogenesis of this tumor-like lesion is still unknown, but a proliferative response of myofibroblasts to hormonal stimuli has been postulated. A large 12 x 9 x 3.5 cm rapidly growing nodular form of PASH of the breast in an 18-year-old woman is here described with clinical and histological findings. A possible hormonal etiology was indicated by elevated progesterone (three-fold) and decreased estrogen serum levels. Different diagnostic lesions, such as giant fibroadenoma and low-grade angiosarcoma, are discussed. To the authors' knowledge this is only the fourth case of nodular PASH of the breast reported in the English literature.


Assuntos
Neoplasias da Mama/diagnóstico , Mama/citologia , Mama/patologia , Neoplasias de Tecido Muscular/patologia , Adolescente , Anovulação , Neoplasias da Mama/patologia , Neoplasias da Mama/cirurgia , Diagnóstico Diferencial , Feminino , Humanos , Hiperplasia/diagnóstico , Hiperplasia/patologia , Progesterona/sangue , Células Estromais/patologia
3.
Rev. colomb. cir ; 15(2): 1-5, jun. 2000. tab
Artigo em Espanhol | LILACS | ID: lil-327552

RESUMO

Presentamos nuestra experiencia con la cirugia laparoscopica de la vesicula biliar en el periodo comprendido entre 1992 y 1998, realizada en instituciones tanto oficiales como privadas de nuestra ciudad. Los datos se recolectaron mediante los archivos de estadistica de dichos centros asistenciales, y a traves de una encuesta telefónica efectuada por los estudiantes de Medicina de VIII semestre de la Facultad de Ciencias para la Salud de la Univ. de Caldas. De un total de 1.325 historias clinicas, se pudo establecer contacto con 967 pacientes, los cuales entraron al estudio y se analizaron segun las diferentes variables.


Assuntos
Colecistite , Colecistectomia Laparoscópica/métodos , Colecistectomia Laparoscópica/tendências , Colecistectomia Laparoscópica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...